Publications by authors named "Wolfgang W Schlenter"
Allergol Select
March 2024
Article Synopsis
- Chronic rhinosinusitis with nasal polyps (CRSwNP) is an inflammatory condition often treated with the anti-IL-5 antibody mepolizumab, which was approved as an additional therapy in 2021 when other treatments fail.
- Current guidelines for using mepolizumab in CRSwNP lack detailed instructions on monitoring, documentation, and discontinuation protocols.
- A literature review led to recommendations for following up on treatment, ensuring adherence to therapy schedules, and guidance on possible therapy interruptions or discontinuation for patients under the German healthcare system.
